Price (delayed)
$4.15
Market cap
$8.41M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.48
Enterprise value
$6.98M
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of disorders involving the nervous system. The Company has
There are no recent dividends present for NURO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.